DRD2 and neoplasm: DA reduces the secretion of prolactin by binding to the dopamine 2 receptor (D2R) in the pituitary tumor, consequently decreasing the tumor volume and lowering the angiogenesis in the surrounding tissue and inducing a tumoricidal effect [18].